Enterome vs ONCOMATRYX
Enterome vs ONCOMATRYX, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and ONCOMATRYX on 50/100.
Where each one leads
Enterome
- our overall score: 60/100 against 50/100
- domain rating: 46/100 against 26/100
- LinkedIn following: 16,846 against 5,170
ONCOMATRYX
- agent readiness: 36/100 against 21/100
At a glance
| Measure | Enterome | ONCOMATRYX |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2012 | 2009 |
| Headquarters | Paris, France | Derio, Spain |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | ONCOMATRYX |
|---|---|---|
| Employees | 33 | 36 |
| Total funding | $124M | $107M |
| Latest round | Later Stage VC | Funding Round |
| LinkedIn followers | 16,846 | 5,170 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | ONCOMATRYX |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 50/100 |
| Traction | 55/100 | 56/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 34/100 | 37/100 |
| Quality | 68/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | ONCOMATRYX |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Segment | Google Analytics 4 |
Enterome vs ONCOMATRYX: common questions
Which is better, Enterome or ONCOMATRYX?
On our 0-100 score Enterome rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Enterome and ONCOMATRYX compare on the numbers?
Enterome leads on our overall score (60/100 against 50/100), domain rating (46/100 against 26/100), LinkedIn following (16,846 against 5,170). ONCOMATRYX leads on agent readiness (36/100 against 21/100).
Read the full Enterome review and pricing or the ONCOMATRYX review and pricing. You can also browse other Enterome alternatives we track.